In a sensitivity analysis excluding participants who progressed from normoglycaemia at baseline to T2D at follow-up, copeptin was also positively associated with incident prediabetes alone (OR [95% CI] 1.43 [1.10; 1.86], P = 0.008; Additional file 1: Table S2). The gene discussed is AVP; the disease is prediabetes syndrome.